A detailed history of Morgan Stanley transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,180,326 shares of AGIO stock, worth $42.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,180,326
Previous 493,587 139.13%
Holding current value
$42.9 Million
Previous $11 Million 213.97%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.32 - $34.81 $14.6 Million - $23.9 Million
686,739 Added 139.13%
1,180,326 $34.5 Million
Q4 2023

Feb 13, 2024

BUY
$19.97 - $24.53 $2.39 Million - $2.93 Million
119,458 Added 31.93%
493,587 $11 Million
Q3 2023

Nov 15, 2023

SELL
$24.36 - $28.18 $422,353 - $488,584
-17,338 Reduced 4.43%
374,129 $9.26 Million
Q2 2023

Aug 14, 2023

BUY
$21.38 - $29.19 $1.73 Million - $2.36 Million
80,685 Added 25.96%
391,467 $11.1 Million
Q1 2023

May 15, 2023

SELL
$21.74 - $30.93 $1.21 Million - $1.72 Million
-55,737 Reduced 15.21%
310,782 $7.14 Million
Q4 2022

Feb 14, 2023

BUY
$24.81 - $31.52 $2.16 Million - $2.74 Million
86,988 Added 31.12%
366,519 $10.3 Million
Q3 2022

Nov 14, 2022

SELL
$19.51 - $34.14 $2.67 Million - $4.66 Million
-136,605 Reduced 32.83%
279,531 $7.91 Million
Q2 2022

Oct 27, 2022

BUY
$17.06 - $31.42 $1.46 Million - $2.69 Million
85,605 Added 25.9%
416,136 $9.23 Million
Q2 2022

Aug 15, 2022

BUY
$17.06 - $31.42 $1.46 Million - $2.69 Million
85,605 Added 25.9%
416,136 $9.23 Million
Q1 2022

Oct 27, 2022

SELL
$26.68 - $34.81 $2.28 Million - $2.98 Million
-85,605 Reduced 20.57%
330,531 $9.62 Million
Q1 2022

May 13, 2022

BUY
$26.68 - $34.81 $1.94 Million - $2.53 Million
72,595 Added 28.14%
330,531 $9.62 Million
Q4 2021

Feb 14, 2022

BUY
$29.58 - $49.78 $2.41 Million - $4.06 Million
81,643 Added 46.31%
257,936 $8.48 Million
Q3 2021

Nov 15, 2021

BUY
$41.92 - $58.18 $7.39 Million - $10.3 Million
176,293 New
176,293 $8.14 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.99B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.